Taysha Gene Therapies, Inc. TSHA Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s free cash flow yield?
- Taysha Gene Therapies, Inc. (TSHA) reported free cash flow yield of -8.7% in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s free cash flow yield changed year-over-year?
- Taysha Gene Therapies, Inc.'s free cash flow yield increased by 70.3% year-over-year, from -29.5% to -8.7%.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s free cash flow yield?
- Over 3 years (2021 to 2025), Taysha Gene Therapies, Inc.'s free cash flow yield has grown at a -43.3% compound annual growth rate (CAGR), from -34.2% to -6.2%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.